Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.1044 | 0.7754 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0131 | 0 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0278 | 0.1247 | 0.031 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0518 | 0.3285 | 0.3344 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0131 | 0 | 0.5 |
Leishmania major | carbonic anhydrase family protein, putative | 0.0542 | 0.3493 | 1 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.0542 | 0.3493 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0131 | 0 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.0131 | 0 | 0.5 |
Schistosoma mansoni | carbonic anhydrase | 0.0542 | 0.3493 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0131 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.1247 | 0.031 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0131 | 0 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0131 | 0 | 0.5 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.0542 | 0.3493 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0131 | 0 | 0.5 |
Onchocerca volvulus | Putative sulfate transporter | 0.0219 | 0.075 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1309 | 1 | 0.5 |
Onchocerca volvulus | 0.0219 | 0.075 | 0.5 | |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0131 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1309 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.122 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.